Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Westin

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|May 25, 2011
Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virusMagnus Lindh, Martin Lagging, Martti Färkkilä, et al.
Scandinavian Journal of Gastroenterology|June 26, 2013
Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapseMartin Lagging, Karolina Rembeck, Mads Rauning Buhl, et al.
Hepatology (Baltimore, Md.)|May 6, 2008
Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infectionMartin Lagging, Nina Langeland, Court Pedersen, et al.
Scandinavian Journal of Gastroenterology|March 29, 2011
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogsEllen Sloth Andersen, Ola Weiland, Peter Leutscher, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 2, 2019
Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infectionsNicklas Sundell, Leif Dotevall, Martina Sansone, et al.
Scandinavian Journal of Primary Health Care|December 1, 2021
Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysisNicolay Jonassen Harbin, Karin Rystedt, Morten Lindbaek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2010
Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?Asa Alsiö, Peer Brehm Christensen, Martti Färkkilä, et al.
Infectious Diseases (London, England)|October 16, 2019
Management of hepatitis B virus infection, updated Swedish guidelinesJohan Westin, Soo Aleman, Maria Castedal, et al.
Scandinavian Journal of Gastroenterology|October 22, 2008
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infectionJohan Westin, Magdalena Ydreborg, Sara Islam, et al.
Plos One|January 19, 2012
Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3Karolina Rembeck, Asa Alsiö, Peer Brehm Christensen, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|May 25, 2011
Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virusMagnus Lindh, Martin Lagging, Martti Färkkilä, et al.
Scandinavian Journal of Gastroenterology|June 26, 2013
Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapseMartin Lagging, Karolina Rembeck, Mads Rauning Buhl, et al.
Hepatology (Baltimore, Md.)|May 6, 2008
Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infectionMartin Lagging, Nina Langeland, Court Pedersen, et al.
Scandinavian Journal of Gastroenterology|March 29, 2011
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogsEllen Sloth Andersen, Ola Weiland, Peter Leutscher, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 2, 2019
Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infectionsNicklas Sundell, Leif Dotevall, Martina Sansone, et al.
Scandinavian Journal of Primary Health Care|December 1, 2021
Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysisNicolay Jonassen Harbin, Karin Rystedt, Morten Lindbaek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2010
Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?Asa Alsiö, Peer Brehm Christensen, Martti Färkkilä, et al.
Infectious Diseases (London, England)|October 16, 2019
Management of hepatitis B virus infection, updated Swedish guidelinesJohan Westin, Soo Aleman, Maria Castedal, et al.
Scandinavian Journal of Gastroenterology|October 22, 2008
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infectionJohan Westin, Magdalena Ydreborg, Sara Islam, et al.
Plos One|January 19, 2012
Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3Karolina Rembeck, Asa Alsiö, Peer Brehm Christensen, et al.
Pageof 10